BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Additional information (Details)			3 Months Ended						9 Months Ended		12 Months Ended
	Aug. 08, 2023 USD ($)	Aug. 08, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) customer $ / shares	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2021 USD ($) customer	Mar. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2022 USD ($) customer $ / shares shares	Jun. 30, 2021 USD ($) customer	Sep. 30, 2021 USD ($) customer
Concentration Risk [Line Items]
Accumulated deficit			$ 291,836,869						$ 291,836,869		$ 284,122,092
Net loss			(1,124,797)	$ (1,759,797)	$ (4,720,911)	$ (3,446,715)	$ (1,517,078)	$ (4,807,062)	(7,605,505)	$ (9,770,855)
Negative operating cash flow									5,718,086	8,675,878
Cash and cash equivalents			4,681,878						4,681,878		$ 6,554,948
Working capital			$ 4,983,408						$ 4,983,408
Common stock, issue price | $ / shares			$ 5.55						$ 5.55
Proceeds from exercise of warrants									$ 75	2,613,929
Number of warrants exercised | shares									748,200
Depreciation method									straight-line method
Excess of FDIC insurance limit			$ 4,000,000.0						$ 4,000,000.0
Transfers from Level 1 to Level 2, Assets			0						0
Transfers from Level 2 to Level 1, Assets			0						0
Transfers from Level 1 to Level 2, Liabilities			0						0
Transfers from Level 2 to Level 1, Liabilities			0						0
Transfers Into Level 3, Assets									0
Transfers out of Level 3, Assets									0
Transfers Into Level 3, Liabilities									0
Transfers out of Level 3, Liabilities									0
Offering costs in aggregate									498,393
Additional paid in capital charges									98,058
Transaction costs related to warrant liabilities			$ 0			$ 0			$ (391,335)	$ 0
Subsequent event | Series B Warrants
Concentration Risk [Line Items]
Proceeds from exercise of warrants	$ 3,600,000	$ 3,600,000
Number of warrants exercised | shares		900,000
Subsequent event | Public Offering
Concentration Risk [Line Items]
Number of shares offered (in shares) | shares		3,000,000
Common stock, issue price | $ / shares		$ 4.00
Gross proceeds		$ 12,000,000
Total Revenue
Concentration Risk [Line Items]
Number of customers | customer			1			1			1	2
Accounts Receivable
Concentration Risk [Line Items]
Number of customers | customer									2		2
Customer Concentration Risk | Total Revenue | One customer
Concentration Risk [Line Items]
Concentration risk percentage			64.00%			30.00%			55.00%	28.00%
Customer Concentration Risk | Total Revenue | Two customer
Concentration Risk [Line Items]
Concentration risk percentage										12.00%
Customer Concentration Risk | Accounts Receivable | Two customer
Concentration Risk [Line Items]
Concentration risk percentage									84.00%		67.00%
Computer equipment
Concentration Risk [Line Items]
Estimated useful life for computer equipment, lab equipment and furniture									3 years
Lab equipment
Concentration Risk [Line Items]
Estimated useful life for computer equipment, lab equipment and furniture									3 years
Furniture
Concentration Risk [Line Items]
Estimated useful life for computer equipment, lab equipment and furniture									3 years